Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
Molecular Therapy - Nucleic Acids - United States
doi 10.1038/mtna.2016.7
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Elsevier BV